TBPH · Theravance Biopharma, Inc.
$16.92
+0.02 (+0.12%)
At close · Aug 6
Market Cap
$871.25M
Shares
51.55M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-29 | 2026-06-28 | |
| 8-K | 2026-06-23 | 2026-06-19 | |
| 8-K | 2026-06-12 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-28 | 2026-06-12 | |
| 8-K | 2026-03-30 | 2026-03-27 | |
| 10-K | 2026-03-23 | 2025-12-31 | |
| 8-K | 2026-03-19 | — | |
| 8-K | 2026-03-03 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-12-08 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-11-10 | — | |
| 8-K | 2025-08-25 | — | |
| 8-K | 2025-08-20 | 2025-08-15 | |
| 10-Q | 2025-08-13 | 2025-06-30 | |
| 8-K | 2025-08-12 | — | |
| 8-K | 2025-06-26 | 2025-06-10 | |
| 8-K | 2025-06-06 | 2025-06-05 | |
| 8-K | 2025-06-02 | 2025-05-30 | |
| 8-K | 2025-05-20 | 2025-05-19 | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| DEF 14A | 2025-04-10 | 2025-05-19 | |
| 10-K | 2025-03-07 | 2024-12-31 | |
| 8-K | 2025-02-26 | — | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 8-K | 2024-11-12 | — | |
| 8-K | 2024-09-23 | 2024-09-18 | |
| 8-K | 2024-09-10 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-05 | — | |
| 10-Q | 2024-05-15 | 2024-03-31 | |
| 8-K | 2024-05-13 | — | |
| 8-K | 2024-05-09 | 2024-05-08 | |
| DEF 14A | 2024-04-05 | 2024-05-08 | |
| 10-K | 2024-03-01 | 2023-12-31 | |
| 8-K | 2024-02-28 | — | |
| 8-K | 2024-02-26 | — | |
| 8-K | 2024-01-16 | 2024-01-12 | |
| 8-K | 2024-01-05 | — | |
| 8-K | 2023-12-28 | 2023-12-26 | |
| 8-K | 2023-12-21 | — | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-11-07 | — | |
| 8-K | 2023-10-30 | 2023-10-27 | |
| 8-K | 2023-09-12 | — | |
| 10-Q | 2023-08-09 | 2023-06-30 | |
| 8-K | 2023-08-07 | — |
Showing 1–50 of 128 filings